Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001213900-25-032715·Hoche Partners Pharma Holding S.A.
Schedule 13D ownership disclosure
PROCAPS GROUP
Ordinary Shares, nominal value of $0.01 per share · CUSIP: L7756P102
Event date: 2025-04-16
- Filing-level shares
- 2,077,549,443.00
- Percent of class
- 84.38%
- Hoche Partners Pharma Holding S.A.Reported CIK 0001884588
Shares: 2,077,549,443.00 · Class: 84.38%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-032715
- Form type
- SCHEDULE 13D/A
- Filer
- Hoche Partners Pharma Holding S.A.
- CIK
- CIK 1884588
- Filed
- Apr 16, 2025
- Reporting period
- Apr 16, 2025
- Description
- Schedule 13D beneficial ownership